SciClone Pharmaceuticals, Inc. (Nasdaq: SCLN) reports Q1 EPS of $0.00, 1 cent lower than ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE